
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/3-MeO-PCP: Difference between revisions
Jump to navigation
Jump to search
>Rhz m Text replacement - "(\|)([A-Za-z]+)ROA_Afterglow=([ ]*)([0-9.]+)([ -]+)([0-9.]+)([ ]*)([^ 0-9]+) " to "$1$2ROA_Afterglow=$2 min afterglow time::$4 - $2 max afterglow time::$6 $2 afterglow time units::$8 " |
>Oskykins No edit summary |
||
Line 59: | Line 59: | ||
|OralROA_Common=[[Oral min common dose::5]] - [[Oral max common dose::7]] mg | |OralROA_Common=[[Oral min common dose::5]] - [[Oral max common dose::7]] mg | ||
|OralROA_Strong=[[Oral min strong dose::7]] - [[Oral max strong dose::10]] mg | |OralROA_Strong=[[Oral min strong dose::7]] - [[Oral max strong dose::10]] mg | ||
|OralROA_Heavy=[[Oral heavy dose::15]]+ | |OralROA_Heavy=[[Oral heavy dose::15]]+ <span style="color:red">'''Heavy doses may result in psychosis and mania.'''</span> | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
Line 76: | Line 76: | ||
|InsufflatedROA_Common=5 - 8 mg | |InsufflatedROA_Common=5 - 8 mg | ||
|InsufflatedROA_Strong=8 - 10 mg | |InsufflatedROA_Strong=8 - 10 mg | ||
|InsufflatedROA_Heavy=10 mg+ | |InsufflatedROA_Heavy=10 mg+ <span style="color:red">'''Heavy doses may result in psychosis and mania.'''</span> | ||
|InsufflatedROA_TimelineFile= | |InsufflatedROA_TimelineFile= | ||
|InsufflatedROA_TimelineWidth= | |InsufflatedROA_TimelineWidth= |
Revision as of 11:00, 3 February 2016
SubstanceBox/3-MeO-PCP | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||
Common names | 3-MeO-PCP | ||||||||||||||||||||||||||||||||||||||||||||
Substitutive name | 3-Methoxyphencyclidine | ||||||||||||||||||||||||||||||||||||||||||||
Systematic name | 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine | ||||||||||||||||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||||||||||||||||
Psychoactive class | Dissociative | ||||||||||||||||||||||||||||||||||||||||||||
Chemical class | Arylcyclohexylamine | ||||||||||||||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||
|